Back
 ABCR  Vol.7 No.1 , January 2018
Decreasing Birth Rate Determining Worldwide Incidence and Regional Variation of Female Breast Cancer
Abstract: Purpose: Urbanization, obesity and ageing associated with life changes (Westernized diet patterns, pollution, physical inactivity) have been proposed as the major contributing factors for the global rise in breast cancer (BCa) and have been the variables used to predict the future breast cancer rate. At the same time, socio-economic level, instead of birth rate, has been proposed for explanation of dramatic regional variations of breast cancer incidence. We sought to determine which factor plays the determining role in predicting worldwide breast cancer incidence rates and regional variations. Methods: Bivariate correlation was conducted to examine the relationships between country-specific estimates of birth rate, BCa incidence, urbanization, overweight, ageing and GDP. Partial correlation was performed to identify the correlation between BCa incidence with each independent variable while we controlled the other four variables. Multiple linear regression was used to identify the most significant predictors of BCa incidence. Post hoc Scheff and independent T-Test analysis were performed to compare mean differences in BCa incidence rates and residuals of BCa standardised on birth rate in the WHO regions, and UN developed and developing regions respectively. Results: Worldwide, BCa incidence rate tends to increase while birth rate decreases and urbanization, overweight, ageing and GDP increase. However, birth rate was the only variable that had a significant correlation with BCa incidence when controlled for the other four variables. Birth rate was the only significant predictor of BCa incidence in regression analysis. Multiple mean differences of BCa incidence between regions were significant, but all disappeared when the contributing effect of birth rate on BCa incidence rate was removed. Conclusions: Birth rate plays a determining role in worldwide BCa incidence rate and regional variations. Current BCa projection methods may estimate future rates of BCa poorly if they fail to incorporate the impact of birth rate.
Cite this paper: You, W. , Symonds, I. , Rühli, F. and Henneberg, M. (2018) Decreasing Birth Rate Determining Worldwide Incidence and Regional Variation of Female Breast Cancer. Advances in Breast Cancer Research, 7, 1-14. doi: 10.4236/abcr.2018.71001.
References

[1]   Stewart, B.W. (2014) World Cancer Report 2014. FRA: International Agency for Research on Cancer, Lyon.

[2]   Chia, K.S., Reilly, M., Tan, C.S., Lee, J., Pawitan, Y., Adami, H.O., Hall, P. and Mow, B. (2005) Profound Changes in Breast Cancer Incidence May Reflect Changes into a Westernized Lifestyle: A Comparative Population-Based Study in Singapore and Sweden. International Journal of Cancer, 113, 302-306.
https://doi.org/10.1002/ijc.20561

[3]   Gage, M., Wattendorf, D. and Henry, L. (2012) Translational Advances Regarding Hereditary Breast Cancer Syndromes. Journal of Surgical Oncology, 105, 444-451.
https://doi.org/10.1002/jso.21856

[4]   McPherson, K., Steel, C. and Dixon, J. (2000) Breast Cancer—Epidemiology, Risk Factors, and Genetics. BMJ, 321, 624-628.
https://doi.org/10.1136/bmj.321.7261.624

[5]   Johnson, K.C., Miller, A.B., Collishaw, N.E., Palmer, J.R., Hammond, S.K., Salmon, A.G., Cantor, K.P., Miller, M.D., Boyd, N.F. and Millar, J. (2009) Active Smoking and Secondhand Smoke Increase Breast Cancer Risk: The Report of the Canadian Expert Panel on Tobacco Smoke and Breast Cancer Risk. Tobacco Control, 2010, Article ID: 035931.

[6]   Centers for Disease Control and Prevention of USA. Cigarette Smoking Among Adults and Trends in Smoking Cessation—United States, 2008.
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5844a2.htm

[7]   Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D.M., Forman, D. and Bray, F. (2013) GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11.
http://globocan.iarc.fr

[8]   Sloan, F.A. and Gelband, H. (2007) Committee on Cancer Control in Low and Middle Income Countries Board on Global Health. The National Academies Press, Washington DC.

[9]   You, W. and Henneberg, M. (2017) Cancer Incidence Increasing Globally: The Role of Relaxed Natural Selection. Evolutionary Applications, 00, 1-13.

[10]   Lee, I.-M., Shiroma, E.J., Lobelo, F., Puska, P., Blair, S.N., Katzmarzyk, P.T., Group LPASW. (2012) Effect of Physical Inactivity on Major Non-Communicable Diseases Worldwide: An Analysis of Burden of Disease and Life Expectancy. The Lancet, 380, 219-229.
https://doi.org/10.1016/S0140-6736(12)61031-9

[11]   Gl, B. (2007) Dietary Fat Reduction and Breast Cancer Outcome: Results from the Women’s Intervention Nutrition Study (WINS). The American Journal of Clinical Nutrition, 86, 878S.

[12]   Sieri, S., Chiodini, P., Agnoli, C., Pala, V., Berrino, F., Trichopoulou, A., Benetou, V., Vasilopoulou, E., Sánchez, M.-J. and Chirlaque, M.-D. (2014) Dietary Fat Intake and Development of Specific Breast Cancer Subtypes. Journal of the National Cancer Institute, 106, dju068.
https://doi.org/10.1093/jnci/dju068

[13]   Cancer Mortality and Morbidity.
http://www.who.int/gho/ncd/mortality_morbidity/cancer_text/en/

[14]   You, W.-P. and Henneberg, M. (2016) Type 1 Diabetes Prevalence Increasing Globally and Regionally: The Role of Natural Selection and Life Expectancy at Birth. BMJ Open Diabetes Research & Care, 4, e000161.
https://doi.org/10.1136/bmjdrc-2015-000161

[15]   Britt, K. and Short, R. (2012) The Plight of Nuns: Hazards of Nulliparity. The Lancet, 379, 2322-2323.
https://doi.org/10.1016/S0140-6736(11)61746-7

[16]   MacMahon, B., Cole, P., Lin, T., Lowe, C., Mirra, A., Ravnihar, B., Salber, E., Valaoras, V. and Yuasa, S. (1970) Age at First Birth and Breast Cancer Risk. Bulletin of the World Health Organization, 43, 209-221.

[17]   Miller, K. (2003) Estrogen and DNA Damage: The Silent Source of Breast Cancer? Journal of the National Cancer Institute, 95, 100-102.
https://doi.org/10.1093/jnci/95.2.100

[18]   Targeted Therapy for Breast Cancer.
http://www.cancer.org

[19]   Dall, G., Risbridger, G. and Britt, K. (2016) Mammary Stem Cells and Parity-Induced Breast Cancer Protection—New Insights. The Journal of Steroid Biochemistry and Molecular Biology, 170, 54-60.

[20]   Faggiano, F., Partanen, T., Kogevinas, M. and Boffetta, P. (1997) Socioeconomic Differences in Cancer Incidence and Mortality. IARC Scientific Publications, 138, 65-176.

[21]   Van Loon, A.J.M., Burg, J., Goldbohm, R.A. and van den Brandt, P.A. (1995) Differences in Cancer Incidence and Mortality among Socio-Economic Groups. Scandinavian Journal of Social Medicine, 23, 110-120.
https://doi.org/10.1177/140349489502300206

[22]   Breast Cancer: Prevention and Control.
http://www.who.int/cancer/detection/breastcancer/en/

[23]   Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D.M., Forman, D. and Bray, F. (2015) Cancer Incidence and Mortality Worldwide: Sources, Methods and Major Patterns in GLOBOCAN 2012. International Journal of Cancer, 136, E359-E386.

[24]   Allender, S., Foster, C., Hutchinson, L. and Arambepola, C. (2008) Quantification of Urbanization in Relation to Chronic Diseases in Developing Countries: A Systematic Review. Journal of Urban Health: Bulletin of the New York Academy of Medicine, 85, 938-951.

[25]   Majeed, A., Babb, P., Jones, J. and Quinn, M. (2000) Trends in Prostate Cancer Incidence, Mortality and Survival in England and Wales 1971-1998. BJU International, 85, 1058-1062.

[26]   Collaborative Group on Hormonal Factors in Breast Cancer (2002) Breast Cancer and Breastfeeding: Collaborative Reanalysis of Individual Data from 47 Epidemiological Studies in 30 Countries, Including 50302 Women with Breast Cancer and 96973 Women without the Disease. The Lancet, 360, 187-195.
https://doi.org/10.1016/S0140-6736(02)09454-0

[27]   Ma, H., Bernstein, L., Pike, M.C. and Ursin, G. (2006) Reproductive Factors and Breast Cancer Risk According to Joint Estrogen and Progesterone Receptor Status: A Meta-Analysis of Epidemiological Studies. Breast Cancer Research, 8, R43.
https://doi.org/10.1186/bcr1525

[28]   Imanieh, M.H., Bagheri, F., Alizadeh, A.M. and Ashkani-Esfahani, S. (2014) Oxytocin Has Therapeutic Effects on Cancer, a Hypothesis. European Journal of Pharmacology, 741, 112-123.
https://doi.org/10.1016/j.ejphar.2014.07.053

[29]   Sapino, A., Macri, L., Tonda, L. and Bussolati, G. (1993) Oxytocin Enhances Myoepithelial Cell Differentiation and Proliferation in the Mouse Mammary Gland. Endocrinology, 133, 838-842.
https://doi.org/10.1210/endo.133.2.8344220

[30]   Cassoni, P., Sapino, A., Negro, F. and Bussolati, G. (1994) Oxytocin Inhibits Proliferation of Human Breast Cancer Cell Lines. Virchows Archiv, 425, 467-472.
https://doi.org/10.1007/BF00197549

[31]   Misra, Y., Bentley, P.A., Bond, J.P., Tighe, S., Hunter, T. and Zhao, F.-Q. (2012) Mammary Gland Morphological and Gene Expression Changes Underlying Pregnancy Protection of Breast Cancer Tumorigenesis. Physiological Genomics, 44, 76-88.
https://doi.org/10.1152/physiolgenomics.00056.2011

[32]   Thompson, W. (1929) Population. American Journal of Sociology, 34, 959-975.
https://doi.org/10.1086/214874

[33]   Winzar, H. (2015) The Ecological Fallacy: How to Spot One and Tips on How to Use One to Your Advantage. Australasian Marketing Journal, 23, 86-92.
https://doi.org/10.1016/j.ausmj.2014.12.002

[34]   Palmer, J.R., Wise, L.A., Horton, N.J., Adams-Campbell, L.L. and Rosenberg, L. (2003) Dual Effect of Parity on Breast Cancer Risk in African-American Women. Journal of the National Cancer Institute, 95, 478-483.
https://doi.org/10.1093/jnci/95.6.478

 
 
Top